Achievement of three year remission with bevacizumab and irinotecan in recurrent glioblastoma multiforme: A case report.
Clinical Medicine Insights: Oncology.
Times cited: 2
Adoptive cellular immunotherapy for the treatment of malignant gliomas.
Critical Reviews in Oncology and Hematology.
Times cited: 49